TransMedics Group Stock Sinks On Q3 Earnings: The Details

TransMedics Group Inc (NASDAQ:TMDX) shares are trading lower in Monday’s after-hours session after the company reported worse-than-expected financial results for the third quarter.

Q3 Revenue: $108.76 million, versus estimates of $115 million

Q3 EPS: 12 cents, versus estimates of 30 cents

Total revenue was up 64% on a year-over-year basis, primarily driven by an increase in utilization of the Organ Care System across all three organs, as well as additional revenue generated by the ...